Aarti Pharmalabs News

Aarti Pharmalabs Files Q4 FY26 SEBI Compliance Certificate

Aarti Pharmalabs Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26, confirming no dematerialisation requests were received during the quarter.

Aarti PharmaLabs Publishes Saksham Niveshak Campaign Ads

Aarti PharmaLabs published newspaper advertisements in Financial Express and Loksatta-Jansatta regarding Second 100-Day Campaign 'Saksham Niveshak' for KYC updation and shareholder engagement under Regulation 30.

Aarti Pharmalabs Launches Saksham Niveshak Campaign

Aarti Pharmalabs initiates Second 100-Day Campaign 'Saksham Niveshak' from April 01 to July 09, 2026, enabling shareholders to claim unpaid dividends and update KYC details before transfer to IEPF.

Aarti Pharmalabs Promoter Pledges 27.84 Lakh Shares

Mr. Mirik Rajendra Gogri pledges 27,84,094 shares (3.08% of total share capital) to Bajaj Financial Securities and 360 One Distribution Services for personal use borrowing of ₹75 crore.

Aarti Pharma Labs Promoter Pledges 15.20 Lakh Shares

Promoter Mr. Renil Rajendra Gogri pledged 15,19,919 shares (1.68% stake) to three financial institutions for personal use, representing 3.89% of his total shareholding in the company.